HENRY SCHEIN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.95 USD | -0.36% |
|
-2.59% | -7.61% |
| Apr. 12 | Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating | MT |
| Apr. 12 | Constellation Brands, Inc: Cash machine |  |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -7.61% | 9.02B | B+ | ||
| +24.86% | 1.84B | B+ | ||
| -12.07% | 1.3B | D | ||
| -20.58% | 854M | - | - | |
| -1.44% | 470M | - | ||
| +7.01% | 453M | - | - | |
| -27.08% | 331M | - | - | |
| -54.71% | 325M | - | ||
| -3.68% | 215M | - | - | |
| +5.73% | 193M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- HSIC Stock
- Ratings Henry Schein, Inc.
